Back to News
Market Impact: 0.42

Microchip Technology stock jumps on data center growth outlook By Investing.com

MCHPBACEVR
Corporate Guidance & OutlookCompany FundamentalsCorporate EarningsProduct LaunchesTechnology & Innovation
Microchip Technology stock jumps on data center growth outlook By Investing.com

Microchip Technology said its Data Center Solutions Business Unit is projected to grow 65% to about $500 million in calendar year 2026, up from $302.7 million in calendar year 2025. The unit posted 62.9% year-over-year growth in the March 2026 quarter, and the stock rose 7% after hours. The company also announced selective price increases across its portfolio due to input cost pressures, but said they will not affect guidance for the fiscal quarter ending June 30, 2026.

Analysis

MCHP’s message is less about a single quarter and more about a re-acceleration in a niche that is becoming strategically more important: low-power connectivity and controller silicon for AI-adjacent infrastructure. If its data-center mix is truly compounding at this pace, the market should start underwriting a higher structural growth rate and a better terminal multiple, because this segment is increasingly the “pick-and-shovel” layer for storage, PCIe/CXL, and switch silicon where design wins tend to be sticky. The second-order winner is likely not just MCHP but also its ecosystem of distributors and board-level suppliers, while pure-play analog/MCU peers with lower AI exposure may look relatively ex-growth. The price increase is also a quiet margin signal: management appears confident enough in demand elasticity to test customer tolerance, which often precedes broader gross-margin upside over the next 1–2 quarters if inventory remains tight. That said, this is still a product-mix story, not a clean cyclical inflection, so a slowdown in hyperscaler capex or design-win delays could quickly cap multiple expansion. The market may be underestimating how much of the stock move is about narrative repair rather than immediate earnings. After a prolonged valuation de-rating, even modest evidence that MCHP can grow above the low-single-digit semis cohort should trigger incremental buying from quality-growth and value-growth crossover funds. The contrarian risk is that investors extrapolate one strong data point into a multi-quarter step-up before we see proof that the growth rate is durable beyond calendar 2026 planning.